Maarten Brom
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 14, 2024
Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas.
Journal: EJNMMI research
Published: December 15, 2023
New Radiolabeled Exendin Analogues Show Reduced Renal Retention.
Journal: Molecular pharmaceutics
Published: June 02, 2023
Monitoring β-Cell Survival After Intrahepatic Islet Transplantation Using Dynamic Exendin PET Imaging: A Proof-of-Concept Study in Individuals With Type 1 Diabetes.
Journal: Diabetes
Published: October 25, 2022
Importance of beta cell mass for glycaemic control in people with type 1 diabetes.
Journal: Diabetologia
Published: June 29, 2022
68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 17, 2021
From Mice to Humans: The Exocrine Pancreas Does Not Matter in Human GLP-1 Receptor Imaging.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 20, 2021
Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis.
Journal: Rheumatology (Oxford, England)
Published: February 27, 2020
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor-Positive Lesions.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 30, 2019
Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 29, 2019
Last Updated: 09/26/2026